CRVS - Corvus gains as Oppenheimer starts with a bullish view on pipeline
2023-08-18 14:20:52 ET
More on Corvus
- Circling Back On Corvus Pharmaceuticals
- Corvus' partner Angel Pharma gets nod to start phase 1/1b trial of cancer therapy in China
- Corvus Pharma initiates Phase 1/1b trial of CPI-818 for T-cell lymphomas in China
- Corvus Pharma extends gains to more than double in value this year
- Seeking Alpha’s Quant Rating on Corvus Pharmaceuticals
For further details see:
Corvus gains as Oppenheimer starts with a bullish view on pipeline